ReNeuron Group PLC (RQE)

London
11.12
-0.12(-1.11%)
  • Volume:
    211,193
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    11.12 - 11.12

RQE Overview

Prev. Close
11.25
Day's Range
11.12-11.12
Revenue
610K
Open
11.25
52 wk Range
8.5-44.5
EPS
-0.134
Volume
211,193
Market Cap
6.31M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
832,077
P/E Ratio
-0.84
Beta
0.904
1-Year Change
-64.7%
Shares Outstanding
57,173,760
Next Earnings Date
Mar 01, 2023
What is your sentiment on ReNeuron?
or
Market is currently closed. Voting is open during market hours.

ReNeuron Group PLC Analysis

ReNeuron Group PLC Company Profile

ReNeuron Group PLC Company Profile

ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a Phase 2a human retinal progenitor cell (hRPC) therapy candidate in retinitis pigmentosa and a Phase 2b immortalized neural progenitor cell therapy candidate (CTX) in stroke. The Company through its induced pluripotent stem cell (iPSC) platform has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellSellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell